Publications (71)

2023

  1. Role of microRNAs in arrhythmogenic cardiomyopathy: translation as biomarkers into clinical practice

    Translational Research

  2. Molecular autopsy: Twenty years of post-mortem diagnosis in sudden cardiac death

    Frontiers in Medicine, Vol. 10

  3. Value of NT-proBNP and Galectin-3 as Biomarkers in the Follow-Up of Asymptomatic Elderly Patients with Severe Aortic Stenosis

    Journal of Clinical Medicine, Vol. 12, Núm. 8

  4. Reevaluation of ambiguous genetic variants in sudden unexplained deaths of a young cohort

    International Journal of Legal Medicine, Vol. 137, Núm. 2, pp. 345-351

  5. Prevalence of transthyretin cardiac amyloidosis in elderly patients diagnosed with heart failure

    Revista Espanola de Geriatria y Gerontologia, Vol. 58, Núm. 1, pp. 8-14

2022

  1. The Role of MicroRNAs in Dilated Cardiomyopathy: New Insights for an Old Entity

    International Journal of Molecular Sciences, Vol. 23, Núm. 21

  2. miR-16-5p Suppression Protects Human Cardiomyocytes against Endoplasmic Reticulum and Oxidative Stress-Induced Injury

    International Journal of Molecular Sciences, Vol. 23, Núm. 3

  3. Impact of COVID-19 on Physical Activity and Lifestyles in Post-Confinement Sports Science Undergraduates

    International journal of environmental research and public health, Vol. 19, Núm. 15

  4. Discerning the Ambiguous Role of Missense TTN Variants in Inherited Arrhythmogenic Syndromes

    Journal of Personalized Medicine, Vol. 12, Núm. 2

  5. Clinical impact of rare variants associated with inherited channelopathies: a 5-year update

    Human Genetics, Vol. 141, Núm. 10, pp. 1579-1589

  6. A microRNA Signature for the Diagnosis of Statins Intolerance

    International Journal of Molecular Sciences, Vol. 23, Núm. 15

2021

  1. Malignant arrhythmogenic role associated with rbm20: A comprehensive interpretation focused on a personalized approach

    Journal of Personalized Medicine, Vol. 11, Núm. 2, pp. 1-17

  2. Rare variants associated with arrhythmogenic cardiomyopathy: Reclassification five years later

    Journal of Personalized Medicine, Vol. 11, Núm. 3, pp. 1-14

  3. Predictive factors of pulmonary embolism in older patients with sars-cov-2: The octa-covid-19 study

    Journal of Clinical Medicine, Vol. 10, Núm. 13

  4. Plasma microrna expression profile for reduced ejection fraction in dilated cardiomyopathy

    Scientific Reports, Vol. 11, Núm. 1

  5. Personalized genetic diagnosis of congenital heart defects in newborns

    Journal of Personalized Medicine, Vol. 11, Núm. 6

  6. Ischemic dilated cardiomyopathy pathophysiology through microRNA-16-5p

    Revista Espanola de Cardiologia, Vol. 74, Núm. 9, pp. 740-749

  7. Elderly population with COVID-19 and the accuracy of clinical scales and d-dimer for pulmonary embolism: The OCTA-COVID study

    Journal of Clinical Medicine, Vol. 10, Núm. 22

  8. Circulating circRNA as biomarkers for dilated cardiomyopathy etiology

    Journal of Molecular Medicine, Vol. 99, Núm. 12, pp. 1711-1725

  9. Asymptomatic aortic stenosis in a geriatric population. The role of frailty and comorbidity in mortality

    Revista Espanola de Cardiologia, Vol. 74, Núm. 2, pp. 167-174